|
[1]
|
WHO. WHO coronavirus (COVID-19) dashboard. 2022. https://covid19.who.int/. [2022-1-8].https://covid19.who.int/ |
|
[2]
|
Bar-On YM, Goldberg Y, Mandel M, Bodenheimer O, Freedman L, Kalkstein N, et al. Protection of BNT162b2 vaccine booster against COVID-19 in Israel. N Engl J Med 2021;385(15):1393 − 400. http://dx.doi.org/10.1056/NEJMoa2114255CrossRef
|
|
[3]
|
Barda N, Dagan N, Cohen C, Hernán MA, Lipsitch M, Kohane IS, et al. Effectiveness of a third dose of the BNT162b2 mRNA COVID-19 vaccine for preventing severe outcomes in Israel: an observational study. Lancet 2021;398(10316):2093 − 100. http://dx.doi.org/10.1016/S0140-6736(21)02249-2CrossRef
|
|
[4]
|
Singanayagam A, Hakki S, Dunning J, Madon KJ, Crone MA, Koycheva A, et al. Community transmission and viral load kinetics of the SARS-CoV-2 delta (B. 1.617.2) variant in vaccinated and unvaccinated individuals in the UK: a prospective, longitudinal, cohort study. Lancet Infect Dis 2022;22(2):183 − 95. http://dx.doi.org/10.1016/S1473-3099(21)00648-4CrossRef
|
|
[5]
|
Ma HL, Wang ZG, Zhao X, Han J, Zhang Y, Wang H, et al. Long distance transmission of SARS-CoV-2 from contaminated cold chain products to humans — Qingdao City, Shandong Province, China, September 2020. China CDC Wkly 2021;3(30):637 − 44. http://dx.doi.org/10.46234/ccdcw2021.164CrossRef
|
|
[6]
|
Li X, Wang Q, Ding P, Cha YE, Mao YX, Ding C, et al. Risk factors and on-site simulation of environmental transmission of SARS-CoV-2 in the largest wholesale market of Beijing, China. Sci Total Environ 2021;778:146040. http://dx.doi.org/10.1016/j.scitotenv.2021.146040CrossRef
|
|
[7]
|
Cai J, Sun WJ, Huang JP, Gamber M, Wu J, He GQ. Indirect virus transmission in cluster of COVID-19 cases, Wenzhou, China, 2020. Emerg Infect Dis 2020;26(6):1343 − 5. http://dx.doi.org/10.3201/eid2606.200412CrossRef
|
|
[8]
|
Li Y, Si HR, Zhu Y, Xie N, Li B, Zhang XP, et al. Characteristics of SARS-CoV-2 transmission in a medium-sized city with traditional communities during the early COVID-19 epidemic in China. Virol Sin 2022. https://doi.org/10.1016/j.virs.2022.01.030.https://doi.org/10.1016/j.virs.2022.01.030 |
|
[9]
|
Liu J, Liu M, Liang WN. The dynamic COVID-zero strategy in China. China CDC Wkly 2022;4(4):74 − 5. http://dx.doi.org/10.46234/ccdcw2022.015CrossRef
|